To investigate its role in breast cancer cells, we first knocked down ITGB4 via siRNA silencing (Figs. 5A and S5A) and found that capabilities of migration and invasion were significantly inhibited in breast cancer cells (Figs. 5B and S5B). Here, ITGB4 is linked to breast carcinoma.